This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Epidemiologic and Survival Characteristics of 59 Patients, 1955-1973

Lawrence S. Krain, MD, MPH

Arch Dermatol. 1974;110(6):862-865.

Abstract
An analysis of 59 patients with pemphigus (including 49 patients with pemphigus vulgaris) was performed at the University of California, Los Angeles hospital from 1955 to 1973. Twenty-nine percent of the patients with pemphigus vulgaris, by virtue of their occupation, had prolonged exposure to various unidentified chemicals prior to the onset of their disease. A comparison of results of our treatment for pemphigus vulgaris with those of other published series indicates that therapy with systemic corticosteroid and immunosuppressive drugs has decreased mortality for pemphigus vulgaris in recent years. The observed five-year survival rate for patients with pemphigus vulgaris was 81.5%. Only four of 49 patients (8.2%) died of the disease or its treatment; the overall mortality for patients with pemphigus vulgaris approximated 26.5% (the mortality for patients with pemphigus foliaceus was 25%).

Author Affiliations
From the Division of Dermatology, University of California, Los Angeles.

Footnotes
Accepted for publication Aug 1, 1974.

Reprint requests to 11734 Wilshire Blvd, Los Angeles, CA 90025 (Dr. Krain).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pemphigus Variant Associated With Penicillin Use: A Case-Cohort Study of 363 Patients From Israel
Heymann et al.
Arch Dermatol 2007;143:704-707.
ABSTRACT | FULL TEXT  

Human Herpesvirus 8 DNA Sequences in Blistering Skin From Patients With Pemphigus
Memar et al.
Arch Dermatol 1997;133:1247-1251.
ABSTRACT  

Treatment of Pemphigus Vulgaris With Brief, High-Dose Intravenous Glucocorticoids
Werth
Arch Dermatol 1996;132:1435-1439.
ABSTRACT  

The Adjuvant Therapy of Pemphigus: An Update
Bystryn and Steinman
Arch Dermatol 1996;132:203-212.
ABSTRACT  

Infection in the Immunocompromised Host
Leyden
Arch Dermatol 1985;121:855-857.
ABSTRACT  

Adjuvant Therapy of Pemphigus
Bystryn
Arch Dermatol 1984;120:941-951.
ABSTRACT  

Pemphigus: Current Concepts
AHMED et al.
ANN INTERN MED 1980;92:396-405.
ABSTRACT  

Immunosuppressants and Prednisone in Pemphigus Vulgaris: Therapeutic Results Obtained in 63 Patients Between 1961 and 1975
Lever and Schaumburg-Lever
Arch Dermatol 1977;113:1236-1241.
ABSTRACT  

Gold Compounds vs Corticosteroids in the Treatment of Pemphigus Vulgaris-Reply
Penneys et al.
Arch Dermatol 1976;112:1467-1467.
ABSTRACT  

Gold Compounds vs Corticosteroids in the Treatment of Pemphigus Vulgaris
Krain
Arch Dermatol 1976;112:1466-1467.
ABSTRACT  

Pemphigus: A 20-Year Review of 107 Patients Treated With Corticosteroids
Rosenberg et al.
Arch Dermatol 1976;112:962-970.
ABSTRACT  

Management of Pemphigus With Gold Compounds: A Long-Term Follow-Up Report
Penneys et al.
Arch Dermatol 1976;112:185-187.
ABSTRACT